New Zealand markets closed

Novartis AG (NVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
106.20-1.02 (-0.95%)
As of 02:18PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 218.14B
Enterprise value 238.70B
Trailing P/E 21.93
Forward P/E 14.81
PEG ratio (5-yr expected) 5.11
Price/sales (ttm)4.53
Price/book (mrq)5.20
Enterprise value/revenue 4.89
Enterprise value/EBITDA 12.58

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 32.10%
S&P500 52-week change 322.23%
52-week high 3112.48
52-week low 392.19
50-day moving average 3105.01
200-day moving average 3100.38

Share statistics

Avg vol (3-month) 31.46M
Avg vol (10-day) 31.7M
Shares outstanding 52.02B
Implied shares outstanding 62.05B
Float 81.95B
% held by insiders 10.00%
% held by institutions 16.94%
Shares short (28 Jun 2024) 46.28M
Short ratio (28 Jun 2024) 44.58
Short % of float (28 Jun 2024) 4N/A
Short % of shares outstanding (28 Jun 2024) 40.31%
Shares short (prior month 31 May 2024) 43.92M

Dividends & splits

Forward annual dividend rate 43.78
Forward annual dividend yield 43.52%
Trailing annual dividend rate 33.92
Trailing annual dividend yield 33.66%
5-year average dividend yield 43.61
Payout ratio 477.24%
Dividend date 319 Apr 2024
Ex-dividend date 407 Mar 2024
Last split factor 21116:1000
Last split date 309 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 31.94%
Operating margin (ttm)30.78%

Management effectiveness

Return on assets (ttm)8.65%
Return on equity (ttm)19.83%

Income statement

Revenue (ttm)47.73B
Revenue per share (ttm)23.17
Quarterly revenue growth (yoy)9.70%
Gross profit (ttm)N/A
EBITDA 18.94B
Net income avi to common (ttm)9.11B
Diluted EPS (ttm)4.89
Quarterly earnings growth (yoy)17.20%

Balance sheet

Total cash (mrq)9.7B
Total cash per share (mrq)4.76
Total debt (mrq)27.28B
Total debt/equity (mrq)68.63%
Current ratio (mrq)0.90
Book value per share (mrq)19.44

Cash flow statement

Operating cash flow (ttm)13.77B
Levered free cash flow (ttm)13.39B